Skip to content

CDR

Diplomat names Daniel Davison as CFO

Diplomat names Daniel Davison as CFO

Diplomat Pharmacy announced Friday that the company’s board of directors has appointed Dan Davison as chief financial officer and treasurer effective April 8, succeeding Atul Kavthekar.

Owen’s Craft Mixers announces deal with Walmart

Owen’s Craft Mixers announces deal with Walmart

Owen’s Craft Mixers, co-founded and co-owned by business partners and brothers-in-law Josh Miller and Tyler Holland, announce a new deal with national retail giant Walmart, part of the company’s continued rapid growth across the country.

NACDS lauds bill to mitigate opioid abuse

NACDS lauds bill to mitigate opioid abuse

The National Association of Chain Drug Stores Friday welcomed Senate legislation that would limit to a seven-day supply the initial prescriptions of opioids for acute pain —  a move that is consistent with Centers for Disease Control and Prevention’s (CDC) guidelines. Sens. Kirsten Gillibrand (D.

Glenmark gets okay for generic acne solution

Glenmark gets okay for generic acne solution

PARAMUS, N.J. – Glenmark Pharmaceuticals has received the Food and Drug Administration’s approval for generic BenzaClin (clindamycin and benzoyl peroxide gel, 1%/5%). The product, which is an acne treatment, is a generic of Valeant Bermuda’s branded product.

JD Beauty to merge with Goody Products

JD Beauty to merge with Goody Products

HAUPPAUGE, N.Y. – JD Beauty, the company behind the popular WetBrush branded hair care accessories, Bio Ionic hair styling tools and Ouidad hair care, announced this week that it will merge with Goody Products.

WBA names Dixon global controller

WBA names Dixon global controller

Heather Dixon has been named senior vice president, global controller and chief accounting officer by Walgreens Boots Alliance Inc, effective March 18. Dixon will join WBA from Aetna Inc.

Rite Aid announces leadership restructuring

Rite Aid announces leadership restructuring

CAMP HILL, PA – Rite Aid Corp. announced Tuesday a leadership transition plan and an organizational restructuring to better align its structure with the company’s operations and to reduce costs. As part of the leadership transition, John Standley will step down as chief executive officer.

Sharpless named acting FDA commissioner

Sharpless named acting FDA commissioner

Dr. Norman “Ned” Sharpless, director of the National Cancer Institute, will become acting commissioner of the Food and Drug Administration next month. Health and Human Services Secretary Alex Azar said Tuesday that Sharpless will take the reins of the FDA after the resignation of Scott Gottlieb.